New ointment shows promise for rare, severe dry skin disease
NCT ID NCT04154293
First seen Jun 09, 2026 · Last updated Jun 12, 2026 · Updated 1 time
Summary
This study tested two strengths of an ointment (TMB-001) in 34 people aged 9 and older with congenital ichthyosis, a rare genetic condition causing thick, scaly skin. The goal was to see if the ointment could safely reduce scaling and improve skin appearance. Participants applied the ointment daily for 12 weeks, and doctors measured changes in skin severity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL ICHTHYOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Austin Institute for Clinical Research, Inc
Metairie, Louisiana, 70005, United States
-
Cincinnati Children's Hospital
Cincinnati, Ohio, 45229, United States
-
Medical Dermatology Specialists
Phoenix, Arizona, 85006, United States
-
Minnesota Clinical Study Center
New Brighton, Minnesota, 55112, United States
-
Murdoch Children's Research Institute, RCH
Melbourne, Victoria, 3052, Australia
-
Premier Specialists, The church
Kogarah, Sydney, NSW 2217, Australia
-
Queensland Children's Hospital
Brisbane, Queensland, 4101, Australia
-
Stanford University School of Medicine
Palo Alto, California, 94304, United States
-
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19140, United States
-
The Indiana Clinical Trials Center
Plainfield, Indiana, 46168, United States
-
Yale Center for Clinical Investigation
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.